Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
40,453,394
-
Shares change
-
+837,435
-
Total reported value, excl. options
-
$291,649,491
-
Value change
-
+$7,414,850
-
Put/Call ratio
-
74%
-
Number of buys
-
91
-
Number of sells
-
65
-
Price
-
$7.21
Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q4 2024
As of 31 Dec 2024 Altimmune, Inc. - Common Stock (ALT) had 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,453,394 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, STATE STREET CORP, TANG CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Knoll Capital Management, LLC, Bellevue Group AG, MORGAN STANLEY, and UBS Group AG.
This table shows 180 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.